Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.
about
Endometriosis, angiogenesis and tissue factorAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge aheadAssessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesisSpecialization of tumour vasculature.Immunotherapy for choroidal neovascularization in a laser-induced mouse model simulating exudative (wet) macular degeneration.Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody.Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.The immunoconjugate "icon" targets aberrantly expressed endothelial tissue factor causing regression of endometriosisNovel therapies targeting endometriosisNatural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancerExpression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factorhI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinoma.Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Tumor angiogenesis therapy using targeted delivery of Paclitaxel to the vasculature of breast cancer metastases.Vascular targeting to the SST2 receptor improves the therapeutic response to near-IR two-photon activated PDT for deep-tissue cancer treatment.Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy.Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms.Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.Tissue factor as a novel target for treatment of breast cancerComparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβTissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma.Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging.Role of tissue factor in cancer.Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy.Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.Targeting tissue factor as a novel therapeutic oncotarget for eradication of cancer stem cells isolated from tumor cell lines, tumor xenografts and patients of breast, lung and ovarian cancer.Chimeric antigen receptor-modified T Cells inhibit the growth and metastases of established tissue factor-positive tumors in NOG miceImmunoPET imaging of tissue factor expression in pancreatic cancer with 89Zr-Df-ALT-836.In vivo quantification of ultrasound targeted microbubbles to enhance cancer assessment.Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way.Fusion protein from RGD peptide and Fc fragment of mouse immunoglobulin G inhibits angiogenesis in tumor.A Pharmacodynamic Analysis of Choroidal Neovascularization in a Porcine Model Using Three Targeted Drugs.The effects of small interfering RNA-targeting tissue factor on an in vitro model of neovascularization.Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.Association between the -402GA, -401GT, and -323ins10-bp polymorphisms of factor VII gene and breast cancer.Early growth response gene-1 and hypoxia-inducible factor-1α affect tumor metastasis via regulation of tissue factor.
P2860
Q27013803-7CD3F4A0-0810-4B9F-A269-8A73387CDE06Q28397132-05E955EE-DCAD-4331-A1C0-CB531B86B24BQ28397726-37595B10-D72C-46B0-945F-7298CCD78AFBQ30896811-AD3CB8B7-B7C6-4583-B0ED-9FB84846E683Q31131792-DF818EE9-6E56-41B4-AC42-7F757D697700Q33279027-921491C8-151D-446C-A35A-435F2073DDD8Q33588136-9E2AA390-3112-4599-9C75-D00DF2767BE9Q33597282-B2007B5A-F9C5-488D-A29E-2B57ECC991B9Q33714186-2DD394C0-F202-4F70-9AEC-2FB20127DC1FQ33715830-BBA1911E-8FE0-4C05-B7EF-9BF5F8ED0F0DQ33938673-7DB3C965-ED87-40A5-A65D-7ACA4ABB696EQ34253625-670016DB-768C-4BD6-B13D-6FCD81589E30Q34287997-0107D3C0-4099-4F1D-B6E2-F370FFB28CCFQ34602545-C97A508C-B357-433F-8A6B-94F4C00F7182Q34755104-8710F6F1-187C-47C2-A095-98AA0D090D52Q34762840-37414DBB-9CF0-4222-B160-099E81D551EFQ35006931-81E417A5-9B46-40FE-A564-FB188CAB6D8AQ35850648-C453A699-F16F-4BD0-8DDF-8FC5C1842F21Q36490167-8FE1F8C9-3672-44BE-95D7-F1EF2D4DEF35Q36565603-F0A21EDD-11DB-4F5D-A810-96E5C0A41BD3Q36852177-793D5F58-FE3F-4B4E-8485-7DDFD3984792Q36972097-36287F3C-1F44-4529-97C8-0772F83E3284Q37030520-238FF246-947C-4592-A325-1AE521F256F4Q37211735-7DD2F19B-E395-4BD8-8F01-6851923D50F9Q37338189-294C7B1A-F95F-44BA-8663-267682FA7333Q37393391-1D13392B-14BF-4B5F-AF9F-1B1F88900E84Q37633792-12833584-8E4F-43BC-91B3-8052CBC95D1FQ37639757-2DADC24D-0B79-4B8E-B0BE-DD21F4E55DE7Q37641624-2F69C0EB-39F6-4FD2-9C9F-867634BEA1D2Q37702117-9328F46F-08D3-4976-9B4A-6DDAB016F295Q37705993-44455CE0-634B-4367-8A0E-138342D52F79Q38607046-B574B2A1-233D-4D13-8FD3-F5E24850D6EAQ39784861-7F9BE009-B51B-4610-AC62-EA2D29301821Q39793065-928050B4-9A14-408C-B5DC-0452E13601F9Q40573323-4AD59419-1BFC-4EA8-AA62-4C6F0A62F798Q41113194-E311E98E-D176-43F5-A23A-E2F969C420EEQ41764457-BA246FDD-09BA-4FA8-9304-9A02A3DE4F56Q42007941-01419842-D1FF-4AE7-A530-C6B9F7AC69EBQ44500187-1E4D4D6F-F071-49F6-A3DC-B3BD07702CFDQ45190913-BEFBFAB0-BD76-4039-BDBD-1F9898ACD33F
P2860
Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Targeting tissue factor on tum ...... se models of prostatic cancer.
@ast
Targeting tissue factor on tum ...... se models of prostatic cancer.
@en
type
label
Targeting tissue factor on tum ...... se models of prostatic cancer.
@ast
Targeting tissue factor on tum ...... se models of prostatic cancer.
@en
prefLabel
Targeting tissue factor on tum ...... se models of prostatic cancer.
@ast
Targeting tissue factor on tum ...... se models of prostatic cancer.
@en
P2860
P356
P1476
Targeting tissue factor on tum ...... se models of prostatic cancer.
@en
P2093
P2860
P304
12180-12185
P356
10.1073/PNAS.201420298
P407
P50
P577
2001-10-02T00:00:00Z